MONTANOVA CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001569064

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2024 · 98 positions · Total reported value $3.13B · Top-10 concentration 44.5% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 47.3% · 21 new · 17 cut · 14 exited

Active Share (vs S&P 500): 88.7% · vs QQQ: 90.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +26.5% · vs SPY +11.7% · Prev Value $3.92B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2024 13F filing, MONTANOVA CAPITAL, LLC disclosed 98 equity positions with a combined reported value of $3.13B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 44.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were SPY ($315.57M), BHVN ($259.80M), KURA ($149.54M). By sector, the heaviest allocations are Health Care 41.8%, Technology 15.7%. Versus the prior quarter, allocation shifted toward Financials (+1.9pp), Consumer Staples (+0.9pp) and away from Other (-1.1pp), Health Care (-3.4pp).

Versus the prior quarter, MONTANOVA CAPITAL, LLC opened 21 new positions, trimmed 17 and fully exited 14, a turnover rate of 47.3% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q3 2024 were SBUX ($53.65M), COF ($35.28M), CRWD ($34.26M).

Of the 14 positions fully exited versus the prior quarter, the largest were ELV ($49.55M), SYY ($37.19M), CMG ($24.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • SBUX STARBUCKS CORP · $53.65M
  • COF CAPITAL ONE FINL CORP · $35.28M
  • CRWD Crowdstrike Holdings Inc · $34.26M
  • BIOA BIOAGE LABS INC · $30.26M
  • KDP KEURIG DR PEPPER INC · $26.35M
  • LVS LAS VEGAS SANDS CORP · $24.37M
  • INTC INTEL CORP · $23.46M
  • WYNN WYNN RESORTS LTD · $12.75M

Fully Exited (vs previous quarter)

  • ELV ELEVANCE HEALTH INC FORMERLY · prev qtr: $49.55M
  • SYY SYSCO CORP · prev qtr: $37.19M · history
  • CMG CHIPOTLE MEXICAN GRILL INC · prev qtr: $24.97M
  • IMTX IMMATICS N.V · prev qtr: $11.00M · history
  • GILD GILEAD SCIENCES INC · prev qtr: $3.48M
  • SYRE SPYRE THERAPEUTICS INC · prev qtr: $2.52M
  • TRML TOURMALINE BIO INC · prev qtr: $1.61M
  • CI Cigna Group/The · prev qtr: $1.59M

Insider Transactions (Form 4)

Latest MONTANOVA CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-20 Opt exercise Veradermics, Inc 151,000 — SEC filing
2026-08-20 Opt exercise Veradermics, Inc 149,000 — SEC filing
2026-08-19 Sell Veradermics, Inc 59,399 $107.25 SEC filing
2026-08-19 Sell Veradermics, Inc 690,601 $107.25 SEC filing

All insider transactions →

Fund Profile

Montanova Capital, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 96 positions worth $5.47B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79962 (status: Approved), registered 2014-06-26
  • Regulatory AUM (Form ADV): $7.87B as of 2026-07-01
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 3 hedge funds
  • Website: montanova.com

Portfolio Structure

  • 96 positions · $5.47B reported value (Q2 2026)
  • Top 10 holdings = 49.1% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 13.0%
  • Average position size: $56.96M

Sector Tilt

  • Health Care 50.9%
  • Information Technology 14.5%
  • Consumer Discretionary 8.3%
  • (classified holdings cover 83% of value)

Quarterly Activity

  • Q2 2026: 21 new, 26 added, 17 reduced, 14 exited
  • 32 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 550.00K $315.57M 10.10%
10.10%
Add
2 5.20M $259.80M 8.31%
8.31%
Hold
3 7.65M $149.54M 4.78%
4.78%
Add
4 1.64M $119.41M 3.82%
3.82%
Reduce
5 1.44M $105.29M 3.37%
3.37%
Reduce
6 10.72M $99.71M 3.19%
3.19%
Add
7 168.49K $96.45M 3.09%
3.09%
Add
8 146.84K $85.86M 2.75%
2.75%
Reduce
9 8.83M $81.14M 2.60%
2.60%
Add
10 336.15K $78.32M 2.51%
2.51%
Reduce
11 352.07K $65.60M 2.10%
2.10%
Reduce
12 1.15M $63.96M 2.05%
2.05%
Reduce
13 348.74K $60.57M 1.94%
1.94%
Reduce
14 7.99M $59.14M 1.89%
1.89%
Reduce
15 465.05K $58.09M 1.86%
1.86%
Add
16 689.95K $57.62M 1.84%
1.84%
Reduce
17 346.57K $56.87M 1.82%
1.82%
Hold
18 550.31K $53.65M 1.72%
1.72%
New
19 108.31K $53.62M 1.72%
1.72%
Add
20 1.87M $52.80M 1.69%
1.69%
Hold
21 193.84K $50.71M 1.62%
1.62%
Add
22 2.29M $50.28M 1.61%
1.61%
Add
23 538.89K $49.98M 1.60%
1.60%
Add
24 4.21M $48.78M 1.56%
1.56%
Hold
25 225.21K $44.72M 1.43%
1.43%
Add
26 1.85M $43.36M 1.39%
1.39%
Add
27 588.91K $42.32M 1.35%
1.35%
Add
28 96.53K $41.54M 1.33%
1.33%
Reduce
29 5.18M $41.35M 1.32%
1.32%
Hold
30 237.09K $40.40M 1.29%
1.29%
Reduce
31 200.66K $37.84M 1.21%
1.21%
Reduce
32 13.77M $37.59M 1.20%
1.20%
Hold
33 235.60K $35.28M 1.13%
1.13%
New
34 122.16K $34.26M 1.10%
1.10%
New
35 758.67K $34.07M 1.09%
1.09%
Add
36 1.72M $32.92M 1.05%
1.05%
Reduce
37 103.64K $31.56M 1.01%
1.01%
Reduce
38 1.46M $30.26M 0.97%
0.97%
New
39 703.10K $26.35M 0.84%
0.84%
New
40 7.19M $24.87M 0.80%
0.80%
Reduce
41 484.11K $24.37M 0.78%
0.78%
New
42 12.34M $23.70M 0.76%
0.76%
Add
43 1.00M $23.46M 0.75%
0.75%
New
44 3.69M $23.29M 0.74%
0.74%
Hold
45 138.45K $22.44M 0.72%
0.72%
Add
46 251.69K $21.09M 0.68%
0.68%
Hold
47 615.91K $19.94M 0.64%
0.64%
Add
48 4.86M $19.74M 0.63%
0.63%
Hold
49 1.66M $14.20M 0.45%
0.45%
Add
50 2.66M $14.09M 0.45%
0.45%
Hold

FAQ

What did MONTANOVA CAPITAL, LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, MONTANOVA CAPITAL, LLC reported 98 equity positions worth $3.13B in aggregate; its largest disclosed positions were SPY ($315.57M), BHVN ($259.80M), KURA ($149.54M).

How large is MONTANOVA CAPITAL, LLC's portfolio?

MONTANOVA CAPITAL, LLC reported $3.13B of long equity holdings across 98 positions as of 2024-Q3. Top-10 holdings account for 44.5% of reported value.

What is MONTANOVA CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/montanova-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →